Karnataka

Kuvempu University is a young affiliating University in Karnataka. Established in 1987, it is a University with a distinctive academic profile, blending in itself commitment to rural ethos and a modern spirit. It has 41 Post-Graduate departments of studies in the faculties of Arts, Science, Commerce, Education and Law. Offering 45 Post-Graduate Programmes, 4 P.G.Diploma and one Under-Graduate programme. The University has 80 affiliated colleges, three  constituent colleges (among three, one is autonomous college) and other one autonomous college, one B.P.Ed. college, and 17 B.Ed. colleges under its jurisdiction spread over 2 districts of Shimoga,  and Chikmagalur. It also has outlying regional Post-Graduate centre at  Kadur.

Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.  We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs. More than a century later, we are passionate about building on this precedent in our continued pursuit to make life better for individuals, communities, and the world around us.

Post : Business Operations Support

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
D.Visagaperumal*, Justin Ebuka Ezekwem, Hemaprasad Munji, Vineeth Chandy
Department of Pharmaceutical Chemistry,
T. John College of Pharmacy, Bangalore, Karnataka, India
*vishak_dr@yahoo.co.in

ABSTRACT
The review article is focused on studies of Isatin-based Schciff Bases and their biological and pharmacological activities. Isatin-based Schiff base are generally synthesized by condensation of the keto group of Isatin with different aromatic primary amines carrying imine or azomethine (–C=N–) functional group. Isatin Schciff Base possesses numerous biological properties like antitumor, antimicrobial, anti-inflammatory, anticonvulsant, antiviral, anti HIV, antioxidant, CNS depressant activities

[adsense:336x280:8701650588]

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries. They have helped over 800 clients to develop and launch some of the most important drugs and devices of our time-helping people live better and healthier lives everywhere in the world. Headquartered near Boston, Massachusetts, PAREXEL operates in more than 50 countries around the world.

Post : Manager Regulatory Affairs

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.  Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.

Post : Specialty Care Advisor

Covance, a $15 billion Fortune 500 company, with operations in over 97 countries, has led the way in improving patient outcomes through visionary data sciences over the last five decades. We have supported 100% of the top 50 drugs in the market and all the oncology medicines approved in 2016. Our team of over 57,000 across the globe is committed to advancing healthcare and bringing new medicines to market sooner. Our unique perspectives, built from decades of scientific expertise and precision delivery, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver the promise of a healthier world.  Together, with our large pharmaceutical and emerging biotech clients, Covance transforms today's health care challenges into tomorrow's solutions.

Post : Clin Apps Programmer I

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967. The Company operates both its Pharmaceuticals and Chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Project Coordinator \/ Manager

YENEPOYA (Deemed to be University) it was named in memory of  the founder late. Mr. Yenepoya Moideen Kunhi and has become one of the leading Universities in the District of Dakshina Kannada (South Canara), Karnataka State, India in the short period since it was founded. The University is consistently rated for the high quality of its teaching, research, healthcare and it has cultivated close and productive links with its local and regional community. Yenepoya Pharmacy College & Research Centre was established in 2017 as a constituent college of YENEPOYA (Deemed to be University) in an intention to provide quality pharmacy education to the people of Karnataka and neighboring districts of Kerala State. The college of Pharmacy is housed in the YENEPOYA (Deemed to be University) campus.  It is an approved research centre for Ph. D. programmes.  In order to produce competent pharmacist workforce to meet the growing demands of the industry and community. It is planned to start the Diploma in Pharmacy program after the successful inspection conducted by the Government of Karnataka and Pharmacy Council of India from the upcoming academic session. In line with our vision, University is optimistic to expand the pharmacy curriculum by introducing M. Pharm and Pharm D. courses.

Post : Assistant Professor in the Department of Pharmacognosy